By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Concert Pharmaceuticals, Inc. 

99 Hayden Avenue
Suite 500
Lexington  Massachusetts  02421  U.S.A.
Phone: 781-860-0045 Fax: n/a



Start Up

Company News
Concert Pharma (CNCE) Reports Second Quarter 2017 Financial Results And Provides Company Update 8/8/2017 6:27:35 AM
Concert Pharma (CNCE) To Report Second Quarter 2017 Financial Results On August 8, 2017 8/1/2017 7:25:36 AM
Vertex (VRTX) And Concert Pharma (CNCE) Complete Asset Purchase Agreement For CTP-656 7/26/2017 7:29:06 AM
Concert Pharma (CNCE) Announces Termination Of The HSR Act Waiting Period For CTP-656 Asset Purchase Agreement With Vertex (VRTX) 7/24/2017 7:52:19 AM
Concert Pharma (CNCE) Jumps As The FDA Lifts Clinical Hold On Hair Loss Drug Study 7/10/2017 5:53:38 AM
Concert Pharma (CNCE) Announces $30 Million Venture Debt Financing From Hercules Capital 6/12/2017 7:27:13 AM
Concert Pharma (CNCE) Announces Departure Of Chief Financial Officer, Ryan Daws 5/30/2017 6:05:54 AM
Concert Pharma (CNCE) Announces Shareholder Approval Of CTP-656 Asset Purchase Agreement With Vertex (VRTX) 5/24/2017 9:17:40 AM
Concert Pharma (CNCE) Receives Second Request From FTC Under HSR Act 5/22/2017 6:12:18 AM
FDA Slaps Clinical Hold on Concert Pharma (CNCE)'s Hair Loss Drug 5/17/2017 5:54:20 AM